HBM Holdings Limited

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, NONOF has a market cap of 196.6B. Regarding current trading prices, HBMHF is priced at $1.56, while NONOF trades at $44.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas NONOF's P/E ratio is 10.29. In terms of profitability, HBMHF's ROE is +0.28%, compared to NONOF's ROE of +0.66%. Regarding short-term risk, HBMHF is more volatile compared to NONOF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check NONOF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, CSLLY has a market cap of 67.5B. Regarding current trading prices, HBMHF is priced at $1.56, while CSLLY trades at $17.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas CSLLY's P/E ratio is 11.32. In terms of profitability, HBMHF's ROE is +0.28%, compared to CSLLY's ROE of +0.08%. Regarding short-term risk, HBMHF is more volatile compared to CSLLY. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check CSLLY's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, UCBJF has a market cap of 54B. Regarding current trading prices, HBMHF is priced at $1.56, while UCBJF trades at $283.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas UCBJF's P/E ratio is 30.20. In terms of profitability, HBMHF's ROE is +0.28%, compared to UCBJF's ROE of +0.15%. Regarding short-term risk, HBMHF is more volatile compared to UCBJF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check UCBJF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, UCBJY has a market cap of 51.8B. Regarding current trading prices, HBMHF is priced at $1.56, while UCBJY trades at $136.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas UCBJY's P/E ratio is 28.95. In terms of profitability, HBMHF's ROE is +0.28%, compared to UCBJY's ROE of +0.15%. Regarding short-term risk, HBMHF is more volatile compared to UCBJY. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check UCBJY's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, ARGNF has a market cap of 49.7B. Regarding current trading prices, HBMHF is priced at $1.56, while ARGNF trades at $803.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas ARGNF's P/E ratio is 35.71. In terms of profitability, HBMHF's ROE is +0.28%, compared to ARGNF's ROE of +0.34%. Regarding short-term risk, HBMHF is more volatile compared to ARGNF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check ARGNF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, CMXHF has a market cap of 32.8B. Regarding current trading prices, HBMHF is priced at $1.56, while CMXHF trades at $68.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas CMXHF's P/E ratio is 11.10. In terms of profitability, HBMHF's ROE is +0.28%, compared to CMXHF's ROE of +0.08%. Regarding short-term risk, HBMHF is more volatile compared to CMXHF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check CMXHF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, IVBXF has a market cap of 17.9B. Regarding current trading prices, HBMHF is priced at $1.56, while IVBXF trades at $10.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas IVBXF's P/E ratio is 147.14. In terms of profitability, HBMHF's ROE is +0.28%, compared to IVBXF's ROE of +0.05%. Regarding short-term risk, HBMHF is more volatile compared to IVBXF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check IVBXF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, WXXWY has a market cap of 17.5B. Regarding current trading prices, HBMHF is priced at $1.56, while WXXWY trades at $8.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas WXXWY's P/E ratio is 24.88. In terms of profitability, HBMHF's ROE is +0.28%, compared to WXXWY's ROE of +0.11%. Regarding short-term risk, HBMHF is more volatile compared to WXXWY. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check WXXWY's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, WXIBF has a market cap of 17.3B. Regarding current trading prices, HBMHF is priced at $1.56, while WXIBF trades at $4.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas WXIBF's P/E ratio is 24.59. In terms of profitability, HBMHF's ROE is +0.28%, compared to WXIBF's ROE of +0.11%. Regarding short-term risk, HBMHF is more volatile compared to WXIBF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check WXIBF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, GNMSF has a market cap of 16.3B. Regarding current trading prices, HBMHF is priced at $1.56, while GNMSF trades at $265.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas GNMSF's P/E ratio is 20.16. In terms of profitability, HBMHF's ROE is +0.28%, compared to GNMSF's ROE of +0.21%. Regarding short-term risk, HBMHF is more volatile compared to GNMSF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check GNMSF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, SBHMY has a market cap of 13.3B. Regarding current trading prices, HBMHF is priced at $1.56, while SBHMY trades at $14.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas SBHMY's P/E ratio is 39.32. In terms of profitability, HBMHF's ROE is +0.28%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, HBMHF is more volatile compared to SBHMY. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check SBHMY's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, SBMFF has a market cap of 12.4B. Regarding current trading prices, HBMHF is priced at $1.56, while SBMFF trades at $0.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas SBMFF's P/E ratio is 23.07. In terms of profitability, HBMHF's ROE is +0.28%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, HBMHF is more volatile compared to SBMFF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check SBMFF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, BRRGF has a market cap of 9.5B. Regarding current trading prices, HBMHF is priced at $1.56, while BRRGF trades at $97.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas BRRGF's P/E ratio is -0.48. In terms of profitability, HBMHF's ROE is +0.28%, compared to BRRGF's ROE of -0.97%. Regarding short-term risk, HBMHF is less volatile compared to BRRGF. This indicates potentially lower risk in terms of short-term price fluctuations for HBMHF.Check BRRGF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, AAVXF has a market cap of 9.2B. Regarding current trading prices, HBMHF is priced at $1.56, while AAVXF trades at $115.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas AAVXF's P/E ratio is -22.11. In terms of profitability, HBMHF's ROE is +0.28%, compared to AAVXF's ROE of -1.65%. Regarding short-term risk, HBMHF is more volatile compared to AAVXF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check AAVXF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, ODTC has a market cap of 8B. Regarding current trading prices, HBMHF is priced at $1.56, while ODTC trades at $22,005.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas ODTC's P/E ratio is 1.07. In terms of profitability, HBMHF's ROE is +0.28%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, HBMHF is more volatile compared to ODTC. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check ODTC's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, AKBLF has a market cap of 7.8B. Regarding current trading prices, HBMHF is priced at $1.56, while AKBLF trades at $38.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas AKBLF's P/E ratio is 42.74. In terms of profitability, HBMHF's ROE is +0.28%, compared to AKBLF's ROE of +0.20%. Regarding short-term risk, HBMHF is more volatile compared to AKBLF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check AKBLF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, REGMF has a market cap of 6.8B. Regarding current trading prices, HBMHF is priced at $1.56, while REGMF trades at $12.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas REGMF's P/E ratio is 63.42. In terms of profitability, HBMHF's ROE is +0.28%, compared to REGMF's ROE of +0.42%. Regarding short-term risk, HBMHF is more volatile compared to REGMF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check REGMF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, TRSBF has a market cap of 6.4B. Regarding current trading prices, HBMHF is priced at $1.56, while TRSBF trades at $2.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas TRSBF's P/E ratio is 5.00. In terms of profitability, HBMHF's ROE is +0.28%, compared to TRSBF's ROE of +0.38%. Regarding short-term risk, HBMHF is more volatile compared to TRSBF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check TRSBF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, HBMHF is priced at $1.56, while ABCZF trades at $22.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, HBMHF's ROE is +0.28%, compared to ABCZF's ROE of +0.29%. Regarding short-term risk, HBMHF is more volatile compared to ABCZF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check ABCZF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, SHJBF has a market cap of 4.8B. Regarding current trading prices, HBMHF is priced at $1.56, while SHJBF trades at $3.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas SHJBF's P/E ratio is -27.92. In terms of profitability, HBMHF's ROE is +0.28%, compared to SHJBF's ROE of -0.11%. Regarding short-term risk, HBMHF is more volatile compared to SHJBF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check SHJBF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, GNNSF has a market cap of 3.8B. Regarding current trading prices, HBMHF is priced at $1.56, while GNNSF trades at $1.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas GNNSF's P/E ratio is -6.90. In terms of profitability, HBMHF's ROE is +0.28%, compared to GNNSF's ROE of -0.13%. Regarding short-term risk, HBMHF is more volatile compared to GNNSF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check GNNSF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, ZLDPF has a market cap of 3.4B. Regarding current trading prices, HBMHF is priced at $1.56, while ZLDPF trades at $48.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas ZLDPF's P/E ratio is 3.45. In terms of profitability, HBMHF's ROE is +0.28%, compared to ZLDPF's ROE of +0.43%. Regarding short-term risk, HBMHF is more volatile compared to ZLDPF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check ZLDPF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, TLPPF has a market cap of 3.3B. Regarding current trading prices, HBMHF is priced at $1.56, while TLPPF trades at $9.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas TLPPF's P/E ratio is -487.50. In terms of profitability, HBMHF's ROE is +0.28%, compared to TLPPF's ROE of -0.02%. Regarding short-term risk, HBMHF is more volatile compared to TLPPF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check TLPPF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, ASPHF has a market cap of 3.2B. Regarding current trading prices, HBMHF is priced at $1.56, while ASPHF trades at $8.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas ASPHF's P/E ratio is -16.00. In terms of profitability, HBMHF's ROE is +0.28%, compared to ASPHF's ROE of -0.73%. Regarding short-term risk, HBMHF is less volatile compared to ASPHF. This indicates potentially lower risk in terms of short-term price fluctuations for HBMHF.Check ASPHF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, BRCTF has a market cap of 2.9B. Regarding current trading prices, HBMHF is priced at $1.56, while BRCTF trades at $33.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas BRCTF's P/E ratio is 26.85. In terms of profitability, HBMHF's ROE is +0.28%, compared to BRCTF's ROE of +0.52%. Regarding short-term risk, HBMHF is more volatile compared to BRCTF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check BRCTF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, HBMHF is priced at $1.56, while MPSYF trades at $73.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, HBMHF's ROE is +0.28%, compared to MPSYF's ROE of -1.84%. Regarding short-term risk, HBMHF is more volatile compared to MPSYF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check MPSYF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, BVNKF has a market cap of 2.3B. Regarding current trading prices, HBMHF is priced at $1.56, while BVNKF trades at $30.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas BVNKF's P/E ratio is 12.78. In terms of profitability, HBMHF's ROE is +0.28%, compared to BVNKF's ROE of +0.09%. Regarding short-term risk, HBMHF is more volatile compared to BVNKF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check BVNKF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, BVNRY has a market cap of 2.3B. Regarding current trading prices, HBMHF is priced at $1.56, while BVNRY trades at $10.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas BVNRY's P/E ratio is 12.67. In terms of profitability, HBMHF's ROE is +0.28%, compared to BVNRY's ROE of +0.09%. Regarding short-term risk, HBMHF is more volatile compared to BVNRY. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check BVNRY's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, INCPF has a market cap of 2.3B. Regarding current trading prices, HBMHF is priced at $1.56, while INCPF trades at $1.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas INCPF's P/E ratio is 25.83. In terms of profitability, HBMHF's ROE is +0.28%, compared to INCPF's ROE of +0.10%. Regarding short-term risk, HBMHF is more volatile compared to INCPF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check INCPF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, MEOBF has a market cap of 2.2B. Regarding current trading prices, HBMHF is priced at $1.56, while MEOBF trades at $1.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas MEOBF's P/E ratio is -24.29. In terms of profitability, HBMHF's ROE is +0.28%, compared to MEOBF's ROE of -0.14%. Regarding short-term risk, HBMHF is more volatile compared to MEOBF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check MEOBF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, GENSF has a market cap of 2.1B. Regarding current trading prices, HBMHF is priced at $1.56, while GENSF trades at $31.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas GENSF's P/E ratio is 32.36. In terms of profitability, HBMHF's ROE is +0.28%, compared to GENSF's ROE of +0.10%. Regarding short-term risk, HBMHF is more volatile compared to GENSF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check GENSF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, GLPGF has a market cap of 1.9B. Regarding current trading prices, HBMHF is priced at $1.56, while GLPGF trades at $28.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas GLPGF's P/E ratio is -3.50. In terms of profitability, HBMHF's ROE is +0.28%, compared to GLPGF's ROE of +0.16%. Regarding short-term risk, HBMHF is more volatile compared to GLPGF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check GLPGF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, PHMMF has a market cap of 1.8B. Regarding current trading prices, HBMHF is priced at $1.56, while PHMMF trades at $106.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas PHMMF's P/E ratio is 46.29. In terms of profitability, HBMHF's ROE is +0.28%, compared to PHMMF's ROE of +0.36%. Regarding short-term risk, HBMHF is more volatile compared to PHMMF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check PHMMF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, ASCLF has a market cap of 1.8B. Regarding current trading prices, HBMHF is priced at $1.56, while ASCLF trades at $1.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas ASCLF's P/E ratio is -33.40. In terms of profitability, HBMHF's ROE is +0.28%, compared to ASCLF's ROE of -0.19%. Regarding short-term risk, HBMHF is more volatile compared to ASCLF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check ASCLF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, ONTTF has a market cap of 1.6B. Regarding current trading prices, HBMHF is priced at $1.56, while ONTTF trades at $1.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas ONTTF's P/E ratio is -8.00. In terms of profitability, HBMHF's ROE is +0.28%, compared to ONTTF's ROE of -0.29%. Regarding short-term risk, HBMHF is more volatile compared to ONTTF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check ONTTF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, CSPHF has a market cap of 1.6B. Regarding current trading prices, HBMHF is priced at $1.56, while CSPHF trades at $1.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas CSPHF's P/E ratio is -20.20. In terms of profitability, HBMHF's ROE is +0.28%, compared to CSPHF's ROE of -0.64%. Regarding short-term risk, HBMHF is more volatile compared to CSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check CSPHF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, HBMHF is priced at $1.56, while BIESF trades at $32.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas BIESF's P/E ratio is -44.44. In terms of profitability, HBMHF's ROE is +0.28%, compared to BIESF's ROE of -0.05%. Regarding short-term risk, HBMHF is more volatile compared to BIESF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check BIESF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, IDRSF has a market cap of 1.4B. Regarding current trading prices, HBMHF is priced at $1.56, while IDRSF trades at $5.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas IDRSF's P/E ratio is -4.36. In terms of profitability, HBMHF's ROE is +0.28%, compared to IDRSF's ROE of +0.19%. Regarding short-term risk, HBMHF is more volatile compared to IDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check IDRSF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, SNBIF has a market cap of 1.3B. Regarding current trading prices, HBMHF is priced at $1.56, while SNBIF trades at $16.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas SNBIF's P/E ratio is -49.85. In terms of profitability, HBMHF's ROE is +0.28%, compared to SNBIF's ROE of -0.89%. Regarding short-term risk, HBMHF is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for HBMHF.Check SNBIF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, MDCLF has a market cap of 1.2B. Regarding current trading prices, HBMHF is priced at $1.56, while MDCLF trades at $34.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas MDCLF's P/E ratio is -47.76. In terms of profitability, HBMHF's ROE is +0.28%, compared to MDCLF's ROE of +0.84%. Regarding short-term risk, HBMHF is more volatile compared to MDCLF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check MDCLF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, NURPF has a market cap of 1.1B. Regarding current trading prices, HBMHF is priced at $1.56, while NURPF trades at $8.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas NURPF's P/E ratio is 52.21. In terms of profitability, HBMHF's ROE is +0.28%, compared to NURPF's ROE of +0.09%. Regarding short-term risk, HBMHF is more volatile compared to NURPF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check NURPF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, CSBTF has a market cap of 975.4M. Regarding current trading prices, HBMHF is priced at $1.56, while CSBTF trades at $24.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas CSBTF's P/E ratio is 309.38. In terms of profitability, HBMHF's ROE is +0.28%, compared to CSBTF's ROE of +0.02%. Regarding short-term risk, HBMHF is more volatile compared to CSBTF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check CSBTF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, BTTAY has a market cap of 943M. Regarding current trading prices, HBMHF is priced at $1.56, while BTTAY trades at $24.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, HBMHF's ROE is +0.28%, compared to BTTAY's ROE of -0.05%. Regarding short-term risk, HBMHF is more volatile compared to BTTAY. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check BTTAY's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, PPTDF has a market cap of 902M. Regarding current trading prices, HBMHF is priced at $1.56, while PPTDF trades at $7.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas PPTDF's P/E ratio is -39.00. In terms of profitability, HBMHF's ROE is +0.28%, compared to PPTDF's ROE of -0.05%. Regarding short-term risk, HBMHF is more volatile compared to PPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check PPTDF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, TKBIF has a market cap of 879M. Regarding current trading prices, HBMHF is priced at $1.56, while TKBIF trades at $7.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas TKBIF's P/E ratio is -14.31. In terms of profitability, HBMHF's ROE is +0.28%, compared to TKBIF's ROE of N/A. Regarding short-term risk, HBMHF is less volatile compared to TKBIF. This indicates potentially lower risk in terms of short-term price fluctuations for HBMHF.Check TKBIF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, PHGUF has a market cap of 875.8M. Regarding current trading prices, HBMHF is priced at $1.56, while PHGUF trades at $1.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas PHGUF's P/E ratio is 62.00. In terms of profitability, HBMHF's ROE is +0.28%, compared to PHGUF's ROE of +0.05%. Regarding short-term risk, HBMHF is more volatile compared to PHGUF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check PHGUF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, BPMUF has a market cap of 805.6M. Regarding current trading prices, HBMHF is priced at $1.56, while BPMUF trades at $65.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas BPMUF's P/E ratio is 9.14. In terms of profitability, HBMHF's ROE is +0.28%, compared to BPMUF's ROE of +0.35%. Regarding short-term risk, HBMHF is more volatile compared to BPMUF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check BPMUF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, IVEVF has a market cap of 741.2M. Regarding current trading prices, HBMHF is priced at $1.56, while IVEVF trades at $5.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas IVEVF's P/E ratio is -2.39. In terms of profitability, HBMHF's ROE is +0.28%, compared to IVEVF's ROE of +18.92%. Regarding short-term risk, HBMHF is more volatile compared to IVEVF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check IVEVF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, SOLTF has a market cap of 613.7M. Regarding current trading prices, HBMHF is priced at $1.56, while SOLTF trades at $6.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas SOLTF's P/E ratio is -7.60. In terms of profitability, HBMHF's ROE is +0.28%, compared to SOLTF's ROE of -0.16%. Regarding short-term risk, HBMHF is more volatile compared to SOLTF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check SOLTF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, CKDXF has a market cap of 601.9M. Regarding current trading prices, HBMHF is priced at $1.56, while CKDXF trades at $0.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, HBMHF's ROE is +0.28%, compared to CKDXF's ROE of +0.84%. Regarding short-term risk, HBMHF is more volatile compared to CKDXF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check CKDXF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, AVCTF has a market cap of 538M. Regarding current trading prices, HBMHF is priced at $1.56, while AVCTF trades at $1.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas AVCTF's P/E ratio is -8.20. In terms of profitability, HBMHF's ROE is +0.28%, compared to AVCTF's ROE of -3.76%. Regarding short-term risk, HBMHF is more volatile compared to AVCTF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check AVCTF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, INRLF has a market cap of 489.3M. Regarding current trading prices, HBMHF is priced at $1.56, while INRLF trades at $2.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas INRLF's P/E ratio is -2.74. In terms of profitability, HBMHF's ROE is +0.28%, compared to INRLF's ROE of -1.06%. Regarding short-term risk, HBMHF is more volatile compared to INRLF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check INRLF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, GNFTF has a market cap of 474.3M. Regarding current trading prices, HBMHF is priced at $1.56, while GNFTF trades at $9.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas GNFTF's P/E ratio is -4.74. In terms of profitability, HBMHF's ROE is +0.28%, compared to GNFTF's ROE of -5.96%. Regarding short-term risk, HBMHF is more volatile compared to GNFTF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check GNFTF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, CYDY has a market cap of 471.3M. Regarding current trading prices, HBMHF is priced at $1.56, while CYDY trades at $0.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas CYDY's P/E ratio is -8.62. In terms of profitability, HBMHF's ROE is +0.28%, compared to CYDY's ROE of +0.37%. Regarding short-term risk, HBMHF is more volatile compared to CYDY. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check CYDY's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, HBMHF is priced at $1.56, while RAONF trades at $2.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas RAONF's P/E ratio is -43.33. In terms of profitability, HBMHF's ROE is +0.28%, compared to RAONF's ROE of -0.26%. Regarding short-term risk, HBMHF is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for HBMHF.Check RAONF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, GNFTY has a market cap of 447.8M. Regarding current trading prices, HBMHF is priced at $1.56, while GNFTY trades at $8.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas GNFTY's P/E ratio is -9.94. In terms of profitability, HBMHF's ROE is +0.28%, compared to GNFTY's ROE of -0.69%. Regarding short-term risk, HBMHF is more volatile compared to GNFTY. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check GNFTY's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, HBMHF is priced at $1.56, while TBGNF trades at $0.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, HBMHF's ROE is +0.28%, compared to TBGNF's ROE of -0.01%. Regarding short-term risk, HBMHF is more volatile compared to TBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check TBGNF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, VBIZF has a market cap of 427.9M. Regarding current trading prices, HBMHF is priced at $1.56, while VBIZF trades at $0.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas VBIZF's P/E ratio is 20.27. In terms of profitability, HBMHF's ROE is +0.28%, compared to VBIZF's ROE of +0.06%. Regarding short-term risk, HBMHF is more volatile compared to VBIZF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check VBIZF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, NWPHF has a market cap of 416.1M. Regarding current trading prices, HBMHF is priced at $1.56, while NWPHF trades at $20.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas NWPHF's P/E ratio is -25.97. In terms of profitability, HBMHF's ROE is +0.28%, compared to NWPHF's ROE of +16.69%. Regarding short-term risk, HBMHF is less volatile compared to NWPHF. This indicates potentially lower risk in terms of short-term price fluctuations for HBMHF.Check NWPHF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, PTCHF has a market cap of 411.4M. Regarding current trading prices, HBMHF is priced at $1.56, while PTCHF trades at $1.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas PTCHF's P/E ratio is -3.67. In terms of profitability, HBMHF's ROE is +0.28%, compared to PTCHF's ROE of -0.32%. Regarding short-term risk, HBMHF is more volatile compared to PTCHF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check PTCHF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, NWBO has a market cap of 403.4M. Regarding current trading prices, HBMHF is priced at $1.56, while NWBO trades at $0.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas NWBO's P/E ratio is -6.28. In terms of profitability, HBMHF's ROE is +0.28%, compared to NWBO's ROE of +0.63%. Regarding short-term risk, HBMHF is more volatile compared to NWBO. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check NWBO's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, CLVLF has a market cap of 343.8M. Regarding current trading prices, HBMHF is priced at $1.56, while CLVLF trades at $6.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas CLVLF's P/E ratio is 14.51. In terms of profitability, HBMHF's ROE is +0.28%, compared to CLVLF's ROE of +0.13%. Regarding short-term risk, HBMHF is more volatile compared to CLVLF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check CLVLF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, SPHDF has a market cap of 337.7M. Regarding current trading prices, HBMHF is priced at $1.56, while SPHDF trades at $23.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas SPHDF's P/E ratio is -4.80. In terms of profitability, HBMHF's ROE is +0.28%, compared to SPHDF's ROE of +6.85%. Regarding short-term risk, HBMHF is more volatile compared to SPHDF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check SPHDF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, CLVLY has a market cap of 333.7M. Regarding current trading prices, HBMHF is priced at $1.56, while CLVLY trades at $6.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas CLVLY's P/E ratio is 14.09. In terms of profitability, HBMHF's ROE is +0.28%, compared to CLVLY's ROE of +0.13%. Regarding short-term risk, HBMHF is more volatile compared to CLVLY. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check CLVLY's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, SCNLF has a market cap of 325.2M. Regarding current trading prices, HBMHF is priced at $1.56, while SCNLF trades at $0.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas SCNLF's P/E ratio is -31.34. In terms of profitability, HBMHF's ROE is +0.28%, compared to SCNLF's ROE of +0.90%. Regarding short-term risk, HBMHF is more volatile compared to SCNLF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check SCNLF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, NGENF has a market cap of 312.9M. Regarding current trading prices, HBMHF is priced at $1.56, while NGENF trades at $3.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas NGENF's P/E ratio is -15.19. In terms of profitability, HBMHF's ROE is +0.28%, compared to NGENF's ROE of -974.60%. Regarding short-term risk, HBMHF is more volatile compared to NGENF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check NGENF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, FGHQF has a market cap of 304.2M. Regarding current trading prices, HBMHF is priced at $1.56, while FGHQF trades at $0.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas FGHQF's P/E ratio is 15.00. In terms of profitability, HBMHF's ROE is +0.28%, compared to FGHQF's ROE of +0.02%. Regarding short-term risk, HBMHF is more volatile compared to FGHQF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check FGHQF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, HBMHF is priced at $1.56, while PBBIF trades at $24.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, HBMHF's ROE is +0.28%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, HBMHF is more volatile compared to PBBIF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check PBBIF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, ORYZF has a market cap of 282.9M. Regarding current trading prices, HBMHF is priced at $1.56, while ORYZF trades at $3.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas ORYZF's P/E ratio is -91.25. In terms of profitability, HBMHF's ROE is +0.28%, compared to ORYZF's ROE of -0.02%. Regarding short-term risk, HBMHF is more volatile compared to ORYZF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check ORYZF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, ORPOF has a market cap of 260.3M. Regarding current trading prices, HBMHF is priced at $1.56, while ORPOF trades at $11.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas ORPOF's P/E ratio is -11.86. In terms of profitability, HBMHF's ROE is +0.28%, compared to ORPOF's ROE of N/A. Regarding short-term risk, HBMHF is more volatile compared to ORPOF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check ORPOF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, HNSBF has a market cap of 245.8M. Regarding current trading prices, HBMHF is priced at $1.56, while HNSBF trades at $2.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas HNSBF's P/E ratio is -3.45. In terms of profitability, HBMHF's ROE is +0.28%, compared to HNSBF's ROE of +2.02%. Regarding short-term risk, HBMHF is more volatile compared to HNSBF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check HNSBF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, HLOSF has a market cap of 236.9M. Regarding current trading prices, HBMHF is priced at $1.56, while HLOSF trades at $2.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas HLOSF's P/E ratio is -12.94. In terms of profitability, HBMHF's ROE is +0.28%, compared to HLOSF's ROE of -0.75%. Regarding short-term risk, HBMHF is more volatile compared to HLOSF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check HLOSF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, CMVLF has a market cap of 222.8M. Regarding current trading prices, HBMHF is priced at $1.56, while CMVLF trades at $3.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas CMVLF's P/E ratio is -4.60. In terms of profitability, HBMHF's ROE is +0.28%, compared to CMVLF's ROE of -0.81%. Regarding short-term risk, HBMHF is more volatile compared to CMVLF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check CMVLF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, BOVNF has a market cap of 216.4M. Regarding current trading prices, HBMHF is priced at $1.56, while BOVNF trades at $3.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas BOVNF's P/E ratio is -7.00. In terms of profitability, HBMHF's ROE is +0.28%, compared to BOVNF's ROE of -0.54%. Regarding short-term risk, HBMHF is more volatile compared to BOVNF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check BOVNF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, IPHYF has a market cap of 211.3M. Regarding current trading prices, HBMHF is priced at $1.56, while IPHYF trades at $2.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas IPHYF's P/E ratio is -3.52. In terms of profitability, HBMHF's ROE is +0.28%, compared to IPHYF's ROE of +5.94%. Regarding short-term risk, HBMHF is more volatile compared to IPHYF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check IPHYF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, HBMHF is priced at $1.56, while FPHAF trades at $3.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, HBMHF's ROE is +0.28%, compared to FPHAF's ROE of +0.00%. Regarding short-term risk, HBMHF is more volatile compared to FPHAF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check FPHAF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, SLNCF has a market cap of 205.8M. Regarding current trading prices, HBMHF is priced at $1.56, while SLNCF trades at $1.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas SLNCF's P/E ratio is -2.69. In terms of profitability, HBMHF's ROE is +0.28%, compared to SLNCF's ROE of -1.15%. Regarding short-term risk, HBMHF is less volatile compared to SLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for HBMHF.Check SLNCF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, PHCUF has a market cap of 196.6M. Regarding current trading prices, HBMHF is priced at $1.56, while PHCUF trades at $7.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas PHCUF's P/E ratio is 21.74. In terms of profitability, HBMHF's ROE is +0.28%, compared to PHCUF's ROE of +0.17%. Regarding short-term risk, HBMHF is more volatile compared to PHCUF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check PHCUF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, SPHRY has a market cap of 192.8M. Regarding current trading prices, HBMHF is priced at $1.56, while SPHRY trades at $4.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas SPHRY's P/E ratio is -76.33. In terms of profitability, HBMHF's ROE is +0.28%, compared to SPHRY's ROE of -0.05%. Regarding short-term risk, HBMHF is more volatile compared to SPHRY. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check SPHRY's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, SPHRF has a market cap of 185.2M. Regarding current trading prices, HBMHF is priced at $1.56, while SPHRF trades at $0.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas SPHRF's P/E ratio is -44.00. In terms of profitability, HBMHF's ROE is +0.28%, compared to SPHRF's ROE of -0.16%. Regarding short-term risk, HBMHF is more volatile compared to SPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check SPHRF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, HBMHF is priced at $1.56, while ADOCY trades at $11.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, HBMHF's ROE is +0.28%, compared to ADOCY's ROE of +8.60%. Regarding short-term risk, HBMHF is more volatile compared to ADOCY. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check ADOCY's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, KNTPF has a market cap of 164.4M. Regarding current trading prices, HBMHF is priced at $1.56, while KNTPF trades at $0.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas KNTPF's P/E ratio is -5.84. In terms of profitability, HBMHF's ROE is +0.28%, compared to KNTPF's ROE of -0.63%. Regarding short-term risk, HBMHF is more volatile compared to KNTPF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check KNTPF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, BBIXF has a market cap of 151.8M. Regarding current trading prices, HBMHF is priced at $1.56, while BBIXF trades at $0.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas BBIXF's P/E ratio is -13.00. In terms of profitability, HBMHF's ROE is +0.28%, compared to BBIXF's ROE of -15.41%. Regarding short-term risk, HBMHF is less volatile compared to BBIXF. This indicates potentially lower risk in terms of short-term price fluctuations for HBMHF.Check BBIXF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, AMGXF has a market cap of 142.5M. Regarding current trading prices, HBMHF is priced at $1.56, while AMGXF trades at $0.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, HBMHF's ROE is +0.28%, compared to AMGXF's ROE of -0.71%. Regarding short-term risk, HBMHF is more volatile compared to AMGXF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check AMGXF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, BRIBF has a market cap of 135.7M. Regarding current trading prices, HBMHF is priced at $1.56, while BRIBF trades at $0.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas BRIBF's P/E ratio is -3.76. In terms of profitability, HBMHF's ROE is +0.28%, compared to BRIBF's ROE of -0.09%. Regarding short-term risk, HBMHF is more volatile compared to BRIBF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check BRIBF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, HBPCF has a market cap of 130.6M. Regarding current trading prices, HBMHF is priced at $1.56, while HBPCF trades at $1.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas HBPCF's P/E ratio is -42.75. In terms of profitability, HBMHF's ROE is +0.28%, compared to HBPCF's ROE of -0.37%. Regarding short-term risk, HBMHF is more volatile compared to HBPCF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check HBPCF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, HBMHF is priced at $1.56, while AAPGV trades at $17.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas AAPGV's P/E ratio is N/A. In terms of profitability, HBMHF's ROE is +0.28%, compared to AAPGV's ROE of -2.50%. Regarding short-term risk, HBMHF is more volatile compared to AAPGV. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check AAPGV's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, TRGNF has a market cap of 122.6M. Regarding current trading prices, HBMHF is priced at $1.56, while TRGNF trades at $0.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas TRGNF's P/E ratio is -2.83. In terms of profitability, HBMHF's ROE is +0.28%, compared to TRGNF's ROE of -0.64%. Regarding short-term risk, HBMHF is more volatile compared to TRGNF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check TRGNF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, HBMHF is priced at $1.56, while PSTTF trades at $0.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, HBMHF's ROE is +0.28%, compared to PSTTF's ROE of N/A. Regarding short-term risk, HBMHF is more volatile compared to PSTTF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check PSTTF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, JWCTF has a market cap of 116.7M. Regarding current trading prices, HBMHF is priced at $1.56, while JWCTF trades at $0.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas JWCTF's P/E ratio is -1.40. In terms of profitability, HBMHF's ROE is +0.28%, compared to JWCTF's ROE of -0.75%. Regarding short-term risk, HBMHF is more volatile compared to JWCTF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check JWCTF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, HBMHF is priced at $1.56, while EPRXF trades at $3.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, HBMHF's ROE is +0.28%, compared to EPRXF's ROE of -4.83%. Regarding short-term risk, HBMHF is more volatile compared to EPRXF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check EPRXF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, HBMHF is priced at $1.56, while ADOIF trades at $8.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, HBMHF's ROE is +0.28%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, HBMHF is more volatile compared to ADOIF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check ADOIF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, MSCLF has a market cap of 96.6M. Regarding current trading prices, HBMHF is priced at $1.56, while MSCLF trades at $6.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas MSCLF's P/E ratio is 2.43. In terms of profitability, HBMHF's ROE is +0.28%, compared to MSCLF's ROE of -0.70%. Regarding short-term risk, HBMHF is more volatile compared to MSCLF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check MSCLF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, MLLCF has a market cap of 95.4M. Regarding current trading prices, HBMHF is priced at $1.56, while MLLCF trades at $2.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas MLLCF's P/E ratio is -1.29. In terms of profitability, HBMHF's ROE is +0.28%, compared to MLLCF's ROE of -0.66%. Regarding short-term risk, HBMHF is more volatile compared to MLLCF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check MLLCF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, NDTP has a market cap of 89.6M. Regarding current trading prices, HBMHF is priced at $1.56, while NDTP trades at $0.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas NDTP's P/E ratio is -4.00. In terms of profitability, HBMHF's ROE is +0.28%, compared to NDTP's ROE of -0.33%. Regarding short-term risk, HBMHF is more volatile compared to NDTP. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check NDTP's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, MCURF has a market cap of 86.5M. Regarding current trading prices, HBMHF is priced at $1.56, while MCURF trades at $0.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas MCURF's P/E ratio is -16.90. In terms of profitability, HBMHF's ROE is +0.28%, compared to MCURF's ROE of -1.02%. Regarding short-term risk, HBMHF is less volatile compared to MCURF. This indicates potentially lower risk in terms of short-term price fluctuations for HBMHF.Check MCURF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, RECEF has a market cap of 80.4M. Regarding current trading prices, HBMHF is priced at $1.56, while RECEF trades at $0.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas RECEF's P/E ratio is -3.67. In terms of profitability, HBMHF's ROE is +0.28%, compared to RECEF's ROE of +2.79%. Regarding short-term risk, HBMHF is less volatile compared to RECEF. This indicates potentially lower risk in terms of short-term price fluctuations for HBMHF.Check RECEF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, ETXPF has a market cap of 76M. Regarding current trading prices, HBMHF is priced at $1.56, while ETXPF trades at $0.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas ETXPF's P/E ratio is -6.50. In terms of profitability, HBMHF's ROE is +0.28%, compared to ETXPF's ROE of -0.51%. Regarding short-term risk, HBMHF is more volatile compared to ETXPF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check ETXPF's competition here

HBMHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HBMHF stands at 1.3B. In comparison, PRRUF has a market cap of 73.7M. Regarding current trading prices, HBMHF is priced at $1.56, while PRRUF trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HBMHF currently has a P/E ratio of 13.00, whereas PRRUF's P/E ratio is -1.25. In terms of profitability, HBMHF's ROE is +0.28%, compared to PRRUF's ROE of -0.53%. Regarding short-term risk, HBMHF is more volatile compared to PRRUF. This indicates potentially higher risk in terms of short-term price fluctuations for HBMHF.Check PRRUF's competition here